# History and Physical

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Clara Barton (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI024-SYN-TD
- Date: 1874-01-20
- Fictional facility: St. Posthumous Health Center
- Fictional author: Eleanor Whitcombe, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## Reason for visit

Primary care visit for low mood, exhaustion, and poor sleep after returning from a long humanitarian deployment. **S**

## Historical basis

- Clarissa Harlowe Barton was born on December 25, 1821, in North Oxford, Massachusetts, the youngest of five children. **D**
- Her diary records a brief period of depression in the spring of 1852, while she was teaching in New Jersey; her biographer judged that the mood did not last long. **D**
- From 1861 she supplied and tended wounded soldiers at battlefields and field hospitals through the Civil War; after working for several days following the Battle of Antietam in September 1862 she was weakened by typhoid fever. **D**
- In her account of the eve of the Battle of Antietam she wrote that she was faint but could not eat, weary but could not sleep, and depressed but could not weep. **D**
- From March 1865 to 1869 she ran an office that answered 63,182 letters and identified 22,000 missing soldiers. **D**
- In December 1868 she lost her voice while giving a lecture, from fatigue and mental prostration; in her own later account, nervous prostration had declared itself and she lay helpless all winter in Washington. **D**
- In September 1869, on her doctor's advice, she travelled to Europe to regain her health. **D**
- During the Franco-Prussian War of 1870 and 1871 she organized civilian relief in Strasbourg, Paris, and other French cities. **D**
- In 1872 and 1873 she suffered nervous exhaustion and temporarily lost her eyesight; in a letter she wrote that she broke down with a cough in England in October 1872 and was confined to bed for eight months. **D**
- After her return in October 1873 she broke down again with what she called prostration of the nervous system, deepened by her only sister's death in May 1874; she wrote that for almost a year she averaged less than two hours of sleep a day and could not write her name for over four months. **D**
- A 1995 review by Spiegel describes her long-term nervous prostration and argues that the therapy she received changed her behavioral approach to illness and to life. **R**
- Her biographer Elizabeth Brown Pryor, as quoted in a 2012 newspaper article, describes a long struggle with depression that was lifted by a need for her services. **R**
- Her mother died on July 18, 1851, and her father on March 21, 1862. **D**

3 later historical claims are omitted because they describe events after the index age. See the teaching note.

These claims are historical evidence, not findings from a real modern examination.

## History of present illness

This fictional modern episode addresses the presenting concerns below. **S**

- Exhausted, low, and sleeping three or four hours a night since coming home; feels she is no use to anyone. **S**
- Worried that stopping work would let down the families and staff who rely on her, and wonders whether she simply needs a long rest. **S**

## Strengths and supports

- Supports: a few close friends from earlier relief work, colleagues at the agency, and a faith community; no firearms in the home **S**

## Medications and allergies

- Sertraline 50 mg oral tablet, one tablet by mouth each morning **S**
- No known allergy **S**

## Past medical history

True biography with historical dates; these events are not part of the synthetic care timeline.

- Spring 1852: Brief period of depression recorded in her diary while teaching **D** (CLM-0002)
- September 1862: Typhoid fever after several days tending the wounded at Antietam **D** (CLM-0003)
- December 1868: Loss of voice during a lecture from fatigue and mental prostration, then helpless through the winter; went to Europe on medical advice the next autumn **D** (CLM-0006, CLM-0007)
- 1872 to 1873: Nervous exhaustion with temporary loss of eyesight; confined to bed for eight months with a cough in England **D** (CLM-0009)
- October 1873: Breakdown with prostration of the nervous system after returning home **D** (CLM-0010)

## Procedures and immunizations

- No procedures before this visit. **S**
- 1873-10-06: Influenza vaccine, 1873-1874 season **S**
- 1872-05-13: Tdap vaccine, before deployment **S**

## Family history

- mother: Died in 1851; cause not recorded in the cited source **D** (CLM-0016)
- father: Died in 1862; cause not recorded in the cited source **D** (CLM-0016)

## Measurements

PHQ-9: 18; GAD-7: 9; PC-PTSD-5: 2; AUDIT-C: 2; Sodium: 139 mmol/L; Potassium: 4.2 mmol/L; Bicarbonate (total CO2): 25 mmol/L; BUN: 14 mg/dL; Creatinine: 0.78 mg/dL; eGFR: 91 mL/min/1.73 m²; Glucose: 92 mg/dL; Hemoglobin: 13.1 g/dL; TSH: 1.8 mIU/L; Vitamin B12: 486 pg/mL. All results are synthetic.

BP 118/74 mmHg; pulse 82 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 49.8 kg; BMI 21.6 kg/m². All vital signs are synthetic.

## Examination

Mental status: Small, upright, neatly dressed; speech soft and slow; good eye contact; cooperative and precise; Mood "worn out and no use to anyone"; affect constricted and tearful at times; thought process linear; no suicidal ideation, intent, or plan; no psychotic features; insight and judgment good. Functional status: At intake, still working but taking twice as long over letters and reports, eating little, and withdrawing from friends; Back at full duties on a 45-hour week by the five-month review, seeing friends weekly, and walking daily. Physical examination is intentionally limited. **S**

## Safety assessment

Current ideation: absent; intent: absent; plan: absent; access reviewed: yes. Disposition: Outpatient care with a collaborative safety plan, the 988 Suicide & Crisis Lifeline, safe storage of medicines, and a two-week follow-up. This is synthetic and does not convert historical behavior into a current finding. **S**

## Assessment

1. Major depressive disorder, recurrent, moderate (moderately severe symptoms at intake), after a prolonged humanitarian deployment; synthetic modern diagnosis linked to her documented periods of depression and nervous prostration; status draft. **S**
2. Occupational burnout after eighteen months leading field medical relief in a war zone; status draft. **S**

## Plan

- Shared decision-making: combined psychotherapy and an antidepressant for a recurrent, moderately severe episode; she chose cognitive behavioral therapy and sertraline. Guideline: VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026) **S**
- Start sertraline 50 mg each morning; check tolerability and safety at two weeks; increase to 100 mg if the PHQ-9 has fallen by less than 50 percent after four to six weeks. Guideline: VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026) **S**
- Weekly cognitive behavioral therapy with the clinic psychologist, by video or in person, for about 16 sessions, including behavioral activation and insomnia components. Guideline: VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026) **S**
- Collaborative safety plan with warning signs, coping steps, people to contact, the clinic number, and the 988 Suicide & Crisis Lifeline; medicines stored safely and dispensed in 30-day supplies. Guideline: VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024) **S**
- Psychiatry consultation to confirm the diagnosis, exclude bipolar disorder and PTSD, and advise on treatment of a recurrent episode. Guideline: VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026) **S**
- PHQ-9 at every visit and at least monthly until remission; suicide-risk review at every visit; continue sertraline for at least twelve months after remission because the episode is recurrent. Guideline: VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026) **S**
- Burnout and work: two weeks of medical leave, then a phased return with a 45-hour cap, no field deployment for at least six months, delegation of the families' correspondence, and a peer support group for relief workers. Guideline: VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026) **S**
- Sleep and activity: fixed wake time, no work after 8 pm, a daily 30-minute walk, regular meals, and limited alcohol; prolonged bed rest or withdrawal from activity is explained as unhelpful for depression. Guideline: VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026) **S**
- Screen for bipolar disorder, PTSD, anxiety, and unhealthy alcohol use, and check thyroid, blood count, vitamin B12, and a metabolic panel for medical contributors to fatigue. Guideline: VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); Depression and Suicide Risk in Adults: Screening (2023) **S**

## Guideline basis

- VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022), United States Department of Veterans Affairs and Department of Defense
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
- CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026), Aether Forge
- Depression and Suicide Risk in Adults: Screening (2023), U.S. Preventive Services Task Force
